Form 4: STERIS CFO Karen Burton Reports Share Transactions

STERIS plc CFO Karen L. Burton reported the vesting of restricted shares, tax-related share withholding, acquisition of new shares, and a grant of employee stock options.

Summary

• Karen L. Burton, Senior Vice President and Chief Financial Officer of STERIS plc, reported changes in her beneficial ownership of company securities.
• On October 1, 2025, 39 ordinary shares were withheld for tax purposes from 86 restricted shares that vested on the same date.
• The 86 ordinary shares that vested were originally awarded to Ms. Burton on October 1, 2021.
• Ms. Burton acquired 2,349 ordinary shares on October 1, 2025, bringing her total direct beneficial ownership of ordinary shares to 8,304.
• Of the 8,304 ordinary shares beneficially owned, 5,479 are restricted with various vesting dates extending through October 1, 2028.
• Ms. Burton was granted 8,356 employee stock options on October 1, 2025, with an exercise price of $265.43 per share.
• These employee stock options will become exercisable in four equal annual installments of 2,089 shares each, starting on October 1, 2026, and expiring on October 1, 2035.

Sentiment

Score: 7

Explanation: The filing details routine executive compensation events, including the vesting of restricted shares, a new grant of shares, and the issuance of stock options, which are generally positive for executive retention and alignment of interests with shareholders.

Positives

• The acquisition of 2,349 ordinary shares increases the CFO's direct equity stake in the company.
• The grant of 8,356 employee stock options aligns the CFO's long-term incentives with shareholder value creation.
• The vesting of 86 restricted shares represents a realization of previously awarded compensation.

Negatives

• 39 ordinary shares were withheld for tax obligations, representing a disposition of shares.

Future Outlook

The future outlook includes the scheduled vesting of 5,479 restricted ordinary shares through October 2028 and the exercisability of 8,356 employee stock options in annual installments from October 2026 through October 2029, with an expiration date of October 2035.

Industry Context

This filing is a routine insider transaction report (Form 4) detailing executive compensation events, which are common across publicly traded companies as a means to align management incentives with shareholder interests. It does not provide broader industry-specific context or trends.

Stakeholder Impact

• Shareholders: Provides transparency into executive stock ownership and compensation, indicating alignment of interests.
• Employees (Executive): Details a portion of the CFO's compensation package, including equity incentives.

Next Steps

• Vesting of 340 restricted ordinary shares on June 1, 2026.
• Vesting of 225 restricted ordinary shares on June 2, 2026.
• Vesting of 651 restricted ordinary shares on June 3, 2026.
• Vesting of 306 restricted ordinary shares on June 4, 2026.
• Vesting of 783 restricted ordinary shares on October 1, 2026.
• 2,089 employee stock options become exercisable on October 1, 2026.
• Further vesting of restricted ordinary shares and exercisability of employee stock options on various dates through October 1, 2029.

Key Dates

Keywords

STERIS, STE, Form 4, Insider Trading, Executive Compensation, Stock Options, Restricted Stock, Share Ownership